ObjectivesLymph node metastasis (LNM) prediction for T1 colorectal cancer (CRC) is critical for determining the need for surgery after endoscopic resection because LNM occurs in 10%. We aimed to develop a novel artificial intelligence (AI) system using whole slide images (WSIs) to predict LNM.MethodsWe conducted a retrospective single center study. To train and test the AI model, we included LNM status‐confirmed T1 and T2 CRC between April 2001 and October 2021. These lesions were divided into two cohorts: training (T1 and T2) and testing (T1). WSIs were cropped into small patches and clustered by unsupervised K‐means. The percentage of patches belonging to each cluster was calculated from each WSI. Each cluster's percentage, sex, and tumor location were extracted and learned using the random forest algorithm. We calculated the areas under the receiver operating characteristic curves (AUCs) to identify the LNM and the rate of over‐surgery of the AI model and the guidelines.ResultsThe training cohort contained 217 T1 and 268 T2 CRCs, while 100 T1 cases (LNM‐positivity 15%) were the test cohort. The AUC of the AI system for the test cohort was 0.74 (95% confidence interval [CI] 0.58–0.86), and 0.52 (95% CI 0.50–0.55) using the guidelines criteria (P = 0.0028). This AI model could reduce the 21% of over‐surgery compared to the guidelines.ConclusionWe developed a pathologist‐independent predictive model for LNM in T1 CRC using WSI for determination of the need for surgery after endoscopic resection.Trial registrationUMIN Clinical Trials Registry (UMIN000046992, https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000053590).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.